Evolution of the Average Target: Viatris Inc.

Evolution of the Average Target - Viatris Inc.

Evolution of the Target Price: Viatris Inc.

Evolution of the Target Price - Viatris Inc.

Changes in Analyst Recommendations: Viatris Inc.

b.4PMN2dxHg5AKf4ydQrR5tm4ZSzj5_9T8OF9YiwMyb78.mrhHlKgBxeUnPNTvAN8V4QRtPg6Qtr-zXzM0xUQHC4q3y3Xu8RPZqWlHzQ~a898ece0e1bc62cd7fc3070b59bef42d
10-21 JPMorgan Adjusts Viatris Price Target to $20 From $18 MT
10-09 Oppenheimer Downgrades Pacira Biosciences to Perform From Outperform on Heels of Announced Sale to Viatris MT
10-05 UBS Adjusts Price Target on Viatris to $26 From $23, Keeps Buy Rating MT
09-23 Viatris Facing Multiple Paths to Earnings Growth, Oppenheimer Says MT
09-23 Oppenheimer Initiates Viatris at Outperform With $25 Price Target MT
09-16 Piper Sandler Adjusts Price Target on Viatris to $13 From $12, Keeps Neutral Rating MT
09-09 Leerink Partners Initiates Viatris at Outperform With $20 Price Target MT
09-08 Argus Adjusts Price Target on Viatris to $20 From $18, Keeps Buy Rating MT
08-19 Viatris' China Policy Concerns Overstated, UBS Says MT
07-22 Goldman Sachs Adjusts Price Target on Viatris to $18 From $17, Maintains Neutral Rating MT
05-27 Argus Raises Viatris Price Target to $18 From $15 MT
05-19 Barclays Adjusts Price Target on Viatris to $22 From $17, Maintains Overweight Rating MT
05-11 UBS Adjusts Viatris Price Target to $23 From $20 MT
05-08 Analyst recommendations: Airbnb , Citigroup , The Walt Disney Company , Block, Cloudflare... Zonebourse
05-05 Goldman Sachs Adjusts Price Target on Viatris to $16 From $14, Maintains Neutral Rating MT
03-23 Barclays Adjusts Viatris Price Target to $17 From $15, Maintains Overweight Rating MT
03-06 Goldman Sachs Adjusts Price Target on Viatris to $14 From $13, Maintains Neutral Rating MT
02-27 Truist Securities Adjusts Price Target on Viatris to $18 From $16, Maintains Buy Rating MT
02-27 UBS Adjusts Viatris Price Target to $20 From $18, Maintains Buy Rating MT
02-27 Jefferies & Co Adjusts Viatris Price Target to $17 From $14, Maintains Buy Rating MT
02-27 JPMorgan Adjusts Price Target on Viatris to $17 From $16, Maintains Neutral Rating MT
02-11 JPMorgan Adjusts Price Target on Viatris to $16 From $14, Maintains Neutral Rating MT
02-09 Viatris Shares Rise After UBS Upgrade MT
02-09 Analyst recommendations: Align, Take-Two, Biogen, PayPal, Stellantis… Zonebourse
02-09 UBS Upgrades Viatris to Buy From Neutral, Adjusts Price Target to $18 From $11 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+10.56%
+4.56%
+5.91%
-0.3%
-1.29%
+9.97%
-1.87%
+22.49%
-9.69%
+2.66%
Average +4.30%
Weighted average by Cap. +3.91%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
18.00USD
Average target price
19.90USD
Spread / Average Target
+10.56%
High Price Target
26.00USD
Spread / Highest target
+44.44%
Low Price Target
13.00USD
Spread / Lowest Target
-27.78%

Analyst Consensus Detail

Analyst consensus - Viatris Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Viatris Inc.
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Viatris Inc.
  1. Stock Market
  2. Stocks
  3. VTRS Stock
  4. Consensus Viatris Inc.